Overactive Bladder

Mirabegron versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review - Beyond the Abstract March 10, 2025

Antibiotic Therapy for Treating Overactive Bladder Is Not Supported by Clinical Evidence - Beyond the Abstract February 27, 2025

Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment - Beyond the Abstract July 23, 2024

Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices - Beyond the Abstract July 1, 2024

Factors Influencing Medication Selection for Management of Overactive Bladder: Trends and Insights from AUA Quality Registry - Beyond the Abstract February 7, 2024

Intradetrusor OnabotulinumtoxinA Injections at the Time of Holmium Laser Enucleation of the Prostate for Men with Overactive Bladder Symptoms - Beyond the Abstract June 26, 2023

Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA - Beyond the Abstract March 20, 2023

The Choice of Therapeutic Agent in Female Overactive Bladder Patients in Real-World Practice - Beyond the Abstract February 22, 2023

Urobiome Changes Differ Based on OAB Treatment in Adult Females - Beyond the Abstract January 17, 2023

A Systematic Review and In Silico Study of Potential Genetic Markers Implicated in Cases of Overactive Bladder - Beyond the Abstract September 29, 2022

Gender Bias in YouTube Videos Describing Common Urology Conditions - Beyond the Abstract September 1, 2022

Combination and Novel Pharmacologic Agents for OAB - Beyond the Abstract August 23, 2022

Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR - Beyond the Abstract May 20, 2022

The Influence of Gut Microbiome on Progression of Overactive Bladder Symptoms: A Community-Based 3-Year Longitudinal Study in Aomori, Japan - Beyond the Abstract February 8, 2022

Social Media Analytics of Overactive Bladder Posts: What do Patients Know and Want to Know? - Beyond the Abstract August 9, 2021

Outcomes of a Single Trigone-Only vs. 20 Trigone-Sparing Injections of OnabotulinumtoxinA for Refractory Overactive Bladder (OAB) - Beyond the Abstract June 1, 2021

Racial and Socioeconomic Factors Influence Utilization of Advanced Therapies in Commercially Insured OAB Patients: An Analysis of over 800,000 OAB Patients - Beyond the Abstract September 14, 2020

Is the Addition of Vaginal Electrical Stimulation to Transcutaneous Tibial Nerve Electrical Stimulation More Effective for Overactive Bladder Treatment? a Randomized Controlled Trial - Beyond the Abstract August 21, 2020

Altered Gut Microbiome Associated with Overactive Bladder and Daily Urinary Urgency - Beyond the Abstract July 7, 2020

Aerococcus Urinae Isolated from Women with Lower Urinary Tract Symptoms: In Vitro Aggregation and Genome Analysis - Beyond the Abstract May 28, 2020

Page 1 of 5